Initially there was no specific way to reverse the anticoagulant so okay I mean you know so uh okay like okay so effect of dabigatran in the event of a um like um uh like so like so like okay major bleeding event, unlike for warfarin, but well you know um you know like well okay well uh okay a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.